A detailed history of Close Asset Management LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Close Asset Management LTD holds 95,214 shares of JNJ stock, worth $13.8 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
95,214
Previous 97,498 2.34%
Holding current value
$13.8 Million
Previous $14.2 Million 8.28%
% of portfolio
0.47%
Previous 0.48%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $332,276 - $382,295
-2,284 Reduced 2.34%
95,214 $15.4 Million
Q2 2024

Aug 07, 2024

BUY
$144.38 - $157.78 $551,820 - $603,035
3,822 Added 4.08%
97,498 $14.2 Million
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $466,436 - $489,033
3,005 Added 3.31%
93,676 $14.8 Million
Q4 2023

Feb 08, 2024

BUY
$145.6 - $158.88 $651,414 - $710,829
4,474 Added 5.19%
90,671 $14.2 Million
Q3 2023

Oct 11, 2023

BUY
$155.75 - $174.48 $680,939 - $762,826
4,372 Added 5.34%
86,197 $13.4 Million
Q2 2023

Jul 26, 2023

BUY
$154.35 - $166.11 $690,253 - $742,843
4,472 Added 5.78%
81,825 $13.5 Million
Q1 2023

Apr 19, 2023

BUY
$151.05 - $180.26 $724,133 - $864,166
4,794 Added 6.61%
77,353 $12 Million
Q4 2022

Jan 27, 2023

BUY
$160.2 - $179.79 $554,131 - $621,893
3,459 Added 5.01%
72,559 $12.8 Million
Q3 2022

Oct 26, 2022

BUY
$161.33 - $179.52 $333,146 - $370,708
2,065 Added 3.08%
69,100 $11.3 Million
Q2 2022

Jul 29, 2022

BUY
$168.19 - $186.01 $401,637 - $444,191
2,388 Added 3.69%
67,035 $11.9 Million
Q4 2021

Jan 27, 2022

SELL
$155.93 - $173.01 $485,098 - $538,234
-3,111 Reduced 4.59%
64,647 $11.1 Million
Q3 2021

Nov 04, 2021

BUY
$161.5 - $179.47 $174,581 - $194,007
1,081 Added 1.62%
67,758 $10.9 Million
Q2 2021

Jul 27, 2021

SELL
$159.48 - $171.07 $336,502 - $360,957
-2,110 Reduced 3.07%
66,677 $11 Million
Q1 2021

May 07, 2021

SELL
$153.07 - $170.48 $172,969 - $192,642
-1,130 Reduced 1.62%
68,787 $11.3 Million
Q4 2020

Jan 22, 2021

BUY
$137.11 - $157.38 $279,567 - $320,897
2,039 Added 3.0%
69,917 $11 Million
Q3 2020

Oct 30, 2020

BUY
$140.38 - $153.83 $24,426 - $26,766
174 Added 0.26%
67,878 $10.1 Million
Q2 2020

Jul 28, 2020

SELL
$128.81 - $155.51 $1.56 Million - $1.89 Million
-12,133 Reduced 15.2%
67,704 $9.51 Million
Q1 2020

May 05, 2020

SELL
$111.14 - $153.99 $3,667 - $5,081
-33 Reduced 0.04%
79,837 $10.5 Million
Q4 2019

Jan 22, 2020

SELL
$127.5 - $146.44 $83,257 - $95,625
-653 Reduced 0.81%
79,870 $11.6 Million
Q3 2019

Nov 06, 2019

SELL
$126.95 - $142.14 $83.8 Million - $93.9 Million
-660,496 Reduced 89.13%
80,523 $10.4 Million
Q2 2019

Aug 01, 2019

BUY
$131.15 - $144.24 $13.7 Million - $15.1 Million
104,411 Added 16.4%
741,019 $103 Million
Q1 2019

May 10, 2019

BUY
$125.72 - $139.79 $79.2 Million - $88.1 Million
630,193 Added 9823.74%
636,608 $89 Million
Q4 2018

Jan 28, 2019

SELL
$122.84 - $147.84 $75.1 Million - $90.4 Million
-611,143 Reduced 98.96%
6,415 $540,000
Q3 2018

Nov 09, 2018

BUY
$121.58 - $142.88 $30.2 Million - $35.5 Million
248,658 Added 67.41%
617,558 $83.7 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $2.83 Million - $3.35 Million
22,639 Added 6.54%
368,900 $45.9 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $8.63 Million - $9.45 Million
65,774 Added 23.45%
346,261 $48.4 Million
Q3 2017

Feb 13, 2018

BUY
$129.47 - $135.38 $12 Million - $12.5 Million
92,450 Added 49.17%
280,487 $0
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $17.3 Million - $18.1 Million
133,461 Added 244.54%
188,037 $24.4 Million
Q2 2017

Feb 13, 2018

BUY
N/A
34,009 Added 165.36%
54,576 $7.22 Million
Q2 2017

Nov 14, 2017

SELL
N/A
-34,313 Reduced 62.52%
20,567 $0
Q1 2017

Feb 13, 2018

BUY
N/A
34,217 Added 165.6%
54,880 $6.83 Million
Q1 2017

Nov 14, 2017

SELL
N/A
-638 Reduced 3.0%
20,663 $2.57 Million
Q4 2016

Nov 14, 2017

BUY
N/A
21,301
21,301 $2.46 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Close Asset Management LTD Portfolio

Follow Close Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.